| abstract |
The invention relates to compounds of the formula I and their pharmaceutically acceptable salts, where the meanings of the radicals R, R and R are disclosed in the claims. The claimed compounds inhibit PI3 kinase and mTOR and are used to treat diseases mediated by PI3 kinase and mTOR, such as various cancers. The invention also relates to pharmaceutical compositions comprising compounds of formula I, including oral administration. |